Hui Li

Dihydroartemisinin as a Putative STAT3 Inhibitor, Suppresses the Growth of Head and Neck Squamous Cell Carcinoma by Targeting Jak2/STAT3 Signaling

Lifeng Jia, Qi Song, Chenyang Zhou et al. · PLoS ONE · 2016 · 76 citations · Full text

Medicine, Oncology, Pharmacology +12

Elevated serum CEA levels are associated with the explosive progression of lung adenocarcinoma harboring EGFR mutations

Yuan Gao, Pingping Song, Hui Li et al. · BMC Cancer · 2017 · 55 citations · Full text

Medicine, Oncology, Pathology +16

Severe Genitourinary Toxicity Following Radiation Therapy for Prostate Cancer—How Long Does it Last?

Sung Hoon Kim, Dirk F. Moore, Weichung Joe Shih et al. · The Journal of Urology · 2012 · 45 citations · Full text

Medicine, Radiation Oncology, Urology +17

Validated LC‐MS/MS method of Sphingosine 1‐phosphate quantification in human serum for evaluation of response to radiotherapy in lung cancer

Xiaohui Tang, Hai‐Sheng Chen, Guanxuan Chen et al. · Thoracic Cancer · 2020 · 22 citations · Full text

Medicine, Oncology, Radiation Oncology +15

Efficacy and safety of iruplinalkib (WX-0593) in ALK-positive crizotinib-resistant advanced non-small cell lung cancer patients: a single-arm, multicenter phase II study (INTELLECT)

Yuankai Shi, Jianhua Chen, Helong Zhang et al. · BMC Medicine · 2023 · 22 citations · Full text

Medicine, Oncology, Pharmacology +15